lilly glp 1 agonist Medscape Eli Lilly to seek approval
Description
Mounjaro (tirzepatide) Drug class: Dual GLP-1/GIP Agonists What is Mounjaro
It should not be described as repairing the gut lining, curing intestinal permeability or treating metabolic disease
2022a;33(5):36478
Only 2.0% of placebo participants achieved 15% weight loss
